Drug Abuse Sourcebook, Sixth Edition, provides updated information about the abuse of illegal drugs and the misuse of prescription and over-the-counter medications.

Table of Contents

• Preface
• Part I: Facts and Statistics about Drug Abuse in the United States
• Chapter 1—Prevalence of Drug Abuse in the United States
• Chapter 2—Drugs: Abuse and Addiction
• Section 2.1—What Is Drug Abuse?
• Section 2.2—What Is Drug Addiction?
• Chapter 3—How Drugs Impact Brain
• Chapter 4—Genetics and Epigenetics of Addiction
• Chapter 5—Drug Abuse and Related Hospitalization Costs
• Section 5.1—Substance Abuse Cost to Society
• Section 5.2—Drug-Related Hospital Emergency Room Visits
• Section 5.3—Increase in Emergency Room Visits Related to Ecstasy
• Section 5.4—Deaths from Drug Overdoses
• Chapter 6—Understanding the Legal Use of Controlled Substances
• Section 6.1—Prescriptions for Controlled Substances
• Section 6.2—Is Marijuana Medicine?
• Chapter 7—Regulations Regarding Controlled Substances
• Section 7.1—The Controlled Substances Act and the Schedule Classifications
• Section 7.2—Combat Methamphetamine Epidemic Act
• Chapter 8—Drugs—Shatter the Myths
• Chapter 9—Substance-Abuse Treatment Statistics
• Part II: Drug Abuse and Specific Populations
• Chapter 10—Adolescent Drug Abuse
• Section 10.1—Trends in Adolescent Drug Abuse
• Section 10.2—Reasons Adolescents Try Drugs and Alcohol
• Section 10.3—Adolescents and Prescription-Drug Misuse
• Section 10.4—Adolescent Marijuana Use
• Section 10.5—Adolescents and Opioids
• Section 10.6—School Dropouts and Substance Abuse
• Chapter 11—Drug Use among College Students
• Chapter 12—Substance-Abuse Issues of Concern to Women
• Section 12.1—Alcohol-Use Disorder,Substance-Use Disorder,and Addiction among Women
• Section 12.2—Substance Use While Pregnant and Breastfeeding
• Section 12.3—Negative Consequences of Prenatal Exposure to Drugs
• Section 12.4—What Women Need to Know about Date Rape Drugs
• Chapter 13—Cigarette Smoking and Tobacco Use among People of Low Socioeconomic Status
• Chapter 14—Substance Abuse in the Workplace
• Chapter 15—Seniors and Drug Abuse
• Chapter 16—Substance Abuse in the LGBT Community
• Chapter 17—Substance Abuse in the Racial and Ethnic Minority Populations
• Chapter 18—Drug Abuse in Other Populations
• Section 18.1—Veterans and Drug Abuse
• Section 18.2—Criminal Justice Populations and Substance Abuse
• Section 18.3—Substance-Use Disorders in People with Disabilities
• Part III: Drugs of Abuse
• Chapter 19—Introduction to Drug Classes
• Chapter 20—Anabolic Steroids and Related Drugs Used as Performance Enhancers
• Section 20.1—Anabolic Steroids
• Section 20.2—Clenbuterol
• Section 20.3—Human Growth Hormone (hGH)
• Chapter 21—Cannabinoids
• Section 21.1—Cannabis and Cannabinoids
• Section 21.2—Synthetic Cannabinoids (K2/Spice)
• Chapter 22—Club Drugs
• Section 22.1—What Are Club Drugs?
• Section 22.2—Gamma-Hydroxybutyrate (GHB)
• Section 22.3—Ketamine
• Section 22.4—Rohypnol
• Chapter 23—Dissociative Drugs
• Section 23.1—Dextromethorphan (DXM)
• Section 23.2—Phencyclidine (PCP)
• Section 23.3—Salvia divinorum
• Chapter 24—Hallucinogenic Drugs
• Section 24.1—Introduction to Hallucinogens
• Section 24.2—4-Iodo-2,5-Dimethoxyphenethylamine
• Section 24.3—Alpha-Methyltryptamine (Spirals)
• Section 24.4—Blue Mystic (2C-T-7)
• Section 24.5—DMT
• Section 24.6—Ecstasy (MDMA)
• Section 24.7—Foxy
• Section 24.8—LSD
• Section 24.9—Mescaline (Peyote)
• Section 24.10—Psilocybin
• Section 24.11—Toonies (Nexus, 2C-B)
• Chapter 25—Inhalants
• Chapter 26—Narcotics (Opioids)
• Section 26.1—Introduction to Narcotics
• Section 26.2—Buprenorphine
• Section 26.3—Fentanyl
• Section 26.4—Heroin
• Section 26.5—Hydrocodone
• Section 26.6—Hydromorphone
• Section 26.7—Methadone
• Section 26.8—Oxycodone
• Chapter 27—Sedatives (Depressants)
• Section 27.1—Introduction to Depressants
• Section 27.2—Barbiturates
• Section 27.3—Benzodiazepines
• Section 27.4—Kava
• Chapter 28—Stimulants
• Section 28.1—Introduction to Stimulants
• Section 28.2—Amphetamine
• Section 28.3—BZP
• Section 28.4—Cocaine
• Section 28.5—Khat
• Section 28.6—Kratom
• Section 28.7—Methamphetamine
• Section 28.8—Methylphenidate
• Chapter 29—Synthetic Drugs
• Section 29.1—What Are Synthetic Drugs?
• Section 29.2—Bath Salts
• Chapter 30—Tobacco, Nicotine, and E-Cigarettes
• Part IV: The Causes and Consequences of Drug Abuse and Addiction
• Chapter 31—Drug Addiction Is a Chronic Disease
• Chapter 32—Common Risk and Protective Factors for Drug Use
• Chapter 33—Prescription and Over-the-Counter Drug Abuse
• Section 33.1—Causes and Prevalence of Prescription-Drug Misuse
• Section 33.2—Over-the-Counter Medicines and Their Misuse
• Section 33.3—Misuse of Over-the-Counter Cough and Cold Medicines
• Chapter 34—Legal, Financial, and Social Consequences of Drug Abuse
• Section 34.1—Legal Consequences of Drug Abuse
• Section 34.2—Financial Consequences of Drug Abuse
• Section 34.3—Drugged Driving
• Chapter 35—Health Consequences of Drug Addiction
• Section 35.1—Poor Health Outcomes of Commonly Abused Drugs
• Section 35.2—Substance Abuse and Medical Complications
• Section 35.3—Marijuana's Long-Term Effects on the Brain
• Section 35.4—Opioid Overdose
• Chapter 36—Preventing Disease in Drug-Abusing Populations
• Section 36.1—Drug Abuse and Infectious Diseases
• Section 36.2—The Connection between HIV/AIDS and Drug Abuse
• Section 36.3—Hepatitis Infection and Drug Use
• Section 36.4—Sterile Syringe Programs
• Chapter 37—Mental Illness and Addiction
• Section 37.1—Addiction and Mental-Health Disorders
• Section 37.2—Depression and Initiation of Alcohol and Drug Abuse in Teens
• Chapter 38—Substance Abuse and Suicide Prevention
• Part V: Drug-Abuse Treatment and Recovery
• Chapter 39—Recognizing Drug Use
• Section 39.1—Signs of Drug Use
• Section 39.2—Am I Drug Addicted?
• Section 39.3—How to Identify Drug Paraphernalia
• Chapter 40—Drug-Abuse Intervention
• Chapter 41—Drug-Abuse Treatment in a Healthcare Setting
• Section 41.1—Medical Professionals Need to Identify Substance-Use Disorders
• Section 41.2—Addiction Treatment Neglected in the Healthcare Setting
• Chapter 42—Detoxification
• Chapter 43—Treatment for Drug Addiction: An Overview
• Chapter 44—Medication and Counseling Treatment
• Section 44.1—What Is Medication and Counseling Treatment?
• Section 44.2—Medication and Counseling Treatment—Buprenorphine
• Section 44.3—Medication and Counseling Treatment—Methadone
• Section 44.4—Medication and Counseling Treatment—Naltrexone
• Section 44.5—Medication and Counseling Treatment—Naloxone
• Section 44.6—Medication and Counseling Treatment—Opioid Overdose
• Chapter 45—Treatment for Methamphetamine Addiction
• Chapter 46—Supporting Substance-Abuse Recovery
• Section 46.1—What Is Recovery?
• Section 46.2—Recovery Support Services
• Chapter 47—Know Your Rights: Parity for Mental-Health and Substance-Use Disorder Benefits
• Chapter 48—Employee-Assistance Programs for Substance Abuse
• Chapter 49—Drug Courts
• Part VI: Drug-Abuse Testing and Prevention
• Chapter 50—Drug-Abuse Prevention Begins at Home
• Section 50.1—Talking to Your Child about Tobacco, Alcohol,and Drugs
• Section 50.2—What to Do If Your Teen or Young Adult Has a Problem with Drugs
• Section 50.3—How to Minimize Prescription-Drug Misuse and Abuse among Teens
• Section 50.4—Tips for Parents: The Truth about Club Drugs
• Chapter 51—Drug-Abuse Testing and Prevention in Schools
• Section 51.1—Drug Testing in Schools
• Section 51.2—Drug-Use Prevention Education in Schools
• Chapter 52—Drug Testing
• Section 52.1—Drug Testing
• Section 52.2—Home-Use Drug Testing
• Chapter 53—Preventing Drug Abuse in the Workplace
• Section 53.1—Drug-Free Workplace Policies
• Section 53.2—Drug Testing in the Workplace
• Chapter 54—Substance-Misuse-Prevention Media Campaigns
• Part VII: Additional Help and Information
• Chapter 55—Glossary of Terms Related to Drug Abuse
• Chapter 56—Glossary of Street Terms for Drugs of Abuse
• Chapter 57—Directory of State Substance-Abuse Agencies
• Chapter 58—Directory of Organizations Providing Information about Drug Abuse